Taiwan Liposome Company, Ltd. (CIK: 0001722890) EDGAR, Information, Filings... CompaniesBIO.Com

Taiwan Liposome Company, Ltd.

Mailing address
2F, 3 YUANQU STREET, NANGANG DISTRICT, TAIPEI CITY, Taiwan, 11503
Phone
886 2 2655 7377
State location
Taiwan
State of incorporation
Taiwan
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Taiwan Liposome Company, Ltd. (CIK: 0001722890) is an American company incorporated in the state of Taiwan. Head office is located at 2F, 3 YUANQU STREET, NANGANG DISTRICT, TAIPEI CITY, Taiwan, 11503. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Taiwan Liposome Company, Ltd. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Taiwan Liposome Company, Ltd.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-22-068586 (34 Act) Size: KB	Mar-08-2022	005-90905 22720229
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-22-046585 (34 Act) Size: KB	Feb-18-2022	005-90905 22652632
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-22-018912 (34 Act) Size: KB	Jan-27-2022	001-38746 22559776
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001564590-22-000726 (34 Act) Size: KB	Jan-10-2022	005-90905 22519385
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001564590-21-056383 (34 Act) Size: KB	Nov-12-2021	005-90905 211398913
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001564590-21-051267 (34 Act) Size: KB	Oct-20-2021	005-90905 211334127
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-299062 (34 Act) Size: KB	Oct-15-2021	005-90905 211324590
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-295441 (34 Act) Size: KB	Oct-08-2021	005-90905 211315312
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001564590-21-050486 (34 Act) Size: KB	Oct-08-2021	001-38746 211314479
25	Document	Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange Acc-no: 0001193125-21-277274 (34 Act) Size: 0 KB	Sep-20-2021	001-38746 211263276
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-273945 (34 Act) Size: KB	Sep-15-2021	005-90905 211255424
F-X	Document	For appointment of agent for service of process by issuers registering securities Acc-no: 0001193125-21-273683 (33 Act) Size: KB	Sep-15-2021	005-90905 211254752
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-267828 (34 Act) Size: KB	Sep-08-2021	005-90905 211242260
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001564590-21-047349 (34 Act) Size: KB	Sep-08-2021	001-38746 211242011
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-266606 (34 Act) Size: KB	Sep-07-2021	005-90905 211239383
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-257574 (34 Act) Size: KB	Aug-26-2021	005-90905 211212452
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001564590-21-045925 (34 Act) Size: KB	Aug-26-2021	001-38746 211212337
CB/A	Document	Amendment to Notification form filed in connection with certain tender offers, business combinations and rights offerings, in which the subject company is a foreign private issuer of which less than 10% of its securities are held by U.S. persons Acc-no: 0001193125-21-255048 (34 Act) Size: KB	Aug-24-2021	005-90905 211202224
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001564590-21-045282 (34 Act) Size: KB	Aug-20-2021	005-90905 211193884
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001564590-21-043690 (34 Act) Size: KB	Aug-12-2021	001-38746 211165865

Recent 20 filings. View all Taiwan Liposome Company, Ltd. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Taiwan Liposome Company, Ltd. overview
Taiwan Liposome Company, Ltd. job
Taiwan Liposome Company, Ltd. stock
Taiwan Liposome Company, Ltd. ownership
Taiwan Liposome Company, Ltd. CEO
Taiwan Liposome Company, Ltd. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.